Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1980 Mar 1;151(3):726–742. doi: 10.1084/jem.151.3.726

Studies of cloned Friend erythroleukemia tumor cells. Modulation of the tumor-specific cytologic T lymphocyte response by infectious Friend virus production in vitro

PMCID: PMC2185809  PMID: 6965703

Abstract

The HFL/b tumor cell line, induced by Friend erythroleukemia virus in BALB.B mice, was used to study the relation between virus production or nonproduction and the antigens recognized by Friend virus-specific cytolytic T lymphocytes (CTL). Analysis of clones and subclones of these tumor cells revealed a high degree of heterogeneity with respect to the production and release into culture fluids of infectious Friend virus in vitro, ranging from high levels to low or undetectable levels of virus production. Although no major differences could be detected among the antibody-defined serotypes of the various clones, the susceptibility of cells of individual HFL/b clones to attack by Friend virus-specific CTL varied widely, and those clones which produced large amounts of infectious virus provided the most sensitive target cells. It was also apparent that production of infectious Friend virus was inhibitory to CTL generation in syngeneic mixed leukocyte-tumor cell cultures. Friend erythroleukemia virus-producing cells thus appeared to interact in a complex manner with the host CTL response by modulating their production of infectious Friend virus.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELRAD A. A., STEEVES R. A. ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE. Virology. 1964 Nov;24:513–518. doi: 10.1016/0042-6822(64)90199-0. [DOI] [PubMed] [Google Scholar]
  2. Blank K. J., Freedman H. A., Lilly F. T-lymphocytes response to Friend virus-induced tumour cell lines in mice of strains congenic at H--2. Nature. 1976 Mar 18;260(5548):250–252. doi: 10.1038/260250a0. [DOI] [PubMed] [Google Scholar]
  3. Brunner K. T., Mauel J., Cerottini J. C., Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology. 1968 Feb;14(2):181–196. [PMC free article] [PubMed] [Google Scholar]
  4. Bubbers J. E., Henney C. S. Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells. J Immunol. 1975 Mar;114(3):1126–1131. [PubMed] [Google Scholar]
  5. Dorval G., Welsh K. I., Wigzell H. Labeled staphylococcal protein A as an immunological probe in the analysis of cell surface markers. Scand J Immunol. 1974;3(4):405–411. doi: 10.1111/j.1365-3083.1974.tb01273.x. [DOI] [PubMed] [Google Scholar]
  6. Enjuanes L., Lee J. C., Ihle J. N. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex. J Immunol. 1979 Feb;122(2):665–674. [PubMed] [Google Scholar]
  7. FRIEND C. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J Exp Med. 1957 Apr 1;105(4):307–318. doi: 10.1084/jem.105.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Freedman H. A., Lilly F. Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice. J Exp Med. 1975 Jul 1;142(1):212–223. doi: 10.1084/jem.142.1.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Freedman H. A., Lilly F., Strand M., August J. T. Variations in viral gene expression in Friend virus-transformed cell lines congenic with respect to the H-2 locus. Cell. 1978 Jan;13(1):33–40. doi: 10.1016/0092-8674(78)90135-6. [DOI] [PubMed] [Google Scholar]
  10. GLYNN J. P., BLANCO A. R., GOLDIN A. STUDIES ON INDUCED RESISTANCE AGAINST ISOTRANSPLANTS OF VIRUS-INDUCED LEUKEMIA. Cancer Res. 1964 Apr;24:502–508. [PubMed] [Google Scholar]
  11. Gillis S., Gillis A. E., Smith K. A. The detection of a spleen focus-forming virus neoantigen by lymphocyte-mediated cytolysis. J Exp Med. 1978 Jul 1;148(1):18–31. doi: 10.1084/jem.148.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  13. Kamo I., Kateley J. R., Kaplan G., Friedman H. Immunosuppression in vitro induced by leukemia virus-infected splenocytes (38544). Proc Soc Exp Biol Med. 1975 Feb;148(2):383–386. doi: 10.3181/00379727-148-38544. [DOI] [PubMed] [Google Scholar]
  14. Mayer A., Duran-Reynals M. L., Lilly F. Fv-1 regulation of lymphoma development and of thymic ecotropic and xenotropic MuLV expression in mice of the AKR/J x RF/J cross. Cell. 1978 Oct;15(2):429–435. doi: 10.1016/0092-8674(78)90012-0. [DOI] [PubMed] [Google Scholar]
  15. McCoy J. L., Fefer A., Glynn J. P. Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems. Cancer Res. 1967 Oct;27(10):1743–1748. [PubMed] [Google Scholar]
  16. Meruelo D. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes. J Exp Med. 1979 Apr 1;149(4):898–909. doi: 10.1084/jem.149.4.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Plata F., Cerottini J. C., Brunner K. T. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system. Eur J Immunol. 1975 Apr;5(4):227–233. doi: 10.1002/eji.1830050402. [DOI] [PubMed] [Google Scholar]
  18. Risser R. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus. J Exp Med. 1979 May 1;149(5):1152–1167. doi: 10.1084/jem.149.5.1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rowe W. P., Pugh W. E., Hartley J. W. Plaque assay techniques for murine leukemia viruses. Virology. 1970 Dec;42(4):1136–1139. doi: 10.1016/0042-6822(70)90362-4. [DOI] [PubMed] [Google Scholar]
  20. Scolnick E. M., Parks W. P. Isolation and characterization of a primate sarcoma virus: mechanism of rescue. Int J Cancer. 1973 Jul 15;12(1):138–147. doi: 10.1002/ijc.2910120115. [DOI] [PubMed] [Google Scholar]
  21. Steeves R. A. Editorial: Spleen focus-forming virus in Friend and Rauscher leukemia virus preparations. J Natl Cancer Inst. 1975 Feb;54(2):289–297. doi: 10.1093/jnci/54.2.289. [DOI] [PubMed] [Google Scholar]
  22. Temin H. M., Baltimore D. RNA-directed DNA synthesis and RNA tumor viruses. Adv Virus Res. 1972;17:129–186. doi: 10.1016/s0065-3527(08)60749-6. [DOI] [PubMed] [Google Scholar]
  23. Ting C. C., Shiu G., Rodrigues D., Herberman R. B. Cell-mediated immunity to Friend virus-induced leukemia. Cancer Res. 1974 Jul;34(7):1684–1687. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES